U.S. flag

An official website of the United States government

NM_001111.5(ADAR):c.3254_3255del (p.Thr1085fs) AND Aicardi-Goutieres syndrome 6

Germline classification:
Likely pathogenic (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001542546.2

Allele description [Variation Report for NM_001111.5(ADAR):c.3254_3255del (p.Thr1085fs)]

NM_001111.5(ADAR):c.3254_3255del (p.Thr1085fs)

Gene:
ADAR:adenosine deaminase RNA specific [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
1q21.3
Genomic location:
Preferred name:
NM_001111.5(ADAR):c.3254_3255del (p.Thr1085fs)
HGVS:
  • NC_000001.11:g.154585814_154585815del
  • NG_011844.2:g.50747_50748del
  • NM_001025107.3:c.2369_2370del
  • NM_001111.5:c.3254_3255delMANE SELECT
  • NM_001193495.2:c.2369_2370del
  • NM_001365045.1:c.3281_3282del
  • NM_001365046.1:c.2369_2370del
  • NM_001365047.1:c.2369_2370del
  • NM_001365048.1:c.2369_2370del
  • NM_001365049.1:c.2291_2292del
  • NM_015840.4:c.3176_3177del
  • NM_015841.4:c.3119_3120del
  • NP_001020278.1:p.Thr790fs
  • NP_001102.3:p.Thr1085fs
  • NP_001180424.1:p.Thr790fs
  • NP_001351974.1:p.Thr1094fs
  • NP_001351975.1:p.Thr790fs
  • NP_001351976.1:p.Thr790fs
  • NP_001351977.1:p.Thr790fs
  • NP_001351978.1:p.Thr764fs
  • NP_056655.3:p.Thr1059fs
  • NP_056656.3:p.Thr1040fs
  • LRG_1212t1:c.3254_3255del
  • LRG_1212:g.50747_50748del
  • LRG_1212p1:p.Thr1085fs
  • NC_000001.10:g.154558289_154558290del
  • NC_000001.10:g.154558290_154558291del
Protein change:
T1040fs
Links:
dbSNP: rs2101563488
NCBI 1000 Genomes Browser:
rs2101563488
Molecular consequence:
  • NM_001025107.3:c.2369_2370del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001111.5:c.3254_3255del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001193495.2:c.2369_2370del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001365045.1:c.3281_3282del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001365046.1:c.2369_2370del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001365047.1:c.2369_2370del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001365048.1:c.2369_2370del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001365049.1:c.2291_2292del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_015840.4:c.3176_3177del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_015841.4:c.3119_3120del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Aicardi-Goutieres syndrome 6 (AGS6)
Identifiers:
MONDO: MONDO:0014007; MedGen: C3539013; Orphanet: 51; OMIM: 615010

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001759984Genomics England Pilot Project, Genomics England
no assertion criteria provided

(ACGS Guidelines, 2016)
Likely pathogenicgermlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Genomics England Pilot Project, Genomics England, SCV001759984.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023